Means Investment Company’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $955K | Sell |
1,813
-3
| -0.2% | -$1.68K | 0.07% | 91 |
|
|
2026
Q1 | $1.02M | Sell |
1,816
-27
| -1% | -$17.3K | 0.09% | 84 |
|
|
2025
Q4 | $1.25M | Hold |
1,843
| – | – | 0.11% | 78 |
|
|
2025
Q3 | $1.18M | Sell |
1,843
-237
| -11% | -$144K | 0.1% | 82 |
|
|
2025
Q2 | $1.12M | Sell |
2,080
-41
| -2% | -$19.6K | 0.11% | 86 |
|
|
2025
Q1 | $891K | Sell |
2,121
-1,213
| -36% | -$527K | 0.09% | 93 |
|
|
2024
Q4 | $1.38M | Sell |
3,334
-45
| -1% | -$19.7K | 0.14% | 79 |
|
|
2024
Q3 | $1.71M | Sell |
3,379
-29
| -0.9% | -$14.1K | 0.19% | 69 |
|
|
2024
Q2 | $1.66M | Sell |
3,408
-69
| -2% | -$34.6K | 0.2% | 64 |
|
|
2024
Q1 | $1.88M | Sell |
3,477
-371
| -10% | -$203K | 0.24% | 64 |
|
|
2023
Q4 | $2.14M | Sell |
3,848
-121
| -3% | -$56.8K | 0.31% | 56 |
|
|
2023
Q3 | $1.74M | Sell |
3,969
-252
| -6% | -$126K | 0.28% | 62 |
|
|
2023
Q2 | $2.12M | Sell |
4,221
-39
| -0.9% | -$18.7K | 0.34% | 55 |
|
|
2023
Q1 | $2.13M | Sell |
4,260
-87
| -2% | -$41.6K | 0.37% | 54 |
|
|
2022
Q4 | $1.77M | Sell |
4,347
-3
| -0.1% | -$1.17K | 0.36% | 65 |
|
|
2022
Q3 | $1.42M | Sell |
4,350
-270
| -6% | -$99.2K | 0.31% | 70 |
|
|
2022
Q2 | $1.62M | Sell |
4,620
-108
| -2% | -$44K | 0.34% | 61 |
|
|
2022
Q1 | $2.59M | Sell |
4,728
-119
| -2% | -$62.6K | 0.47% | 43 |
|
|
2021
Q4 | $3.19M | Sell |
4,847
-103
| -2% | -$64.7K | 0.56% | 36 |
|
|
2021
Q3 | $3.08M | Sell |
4,950
-104
| -2% | -$69.9K | 0.61% | 36 |
|
|
2021
Q2 | $3.19M | Sell |
5,054
-120
| -2% | -$66.3K | 0.64% | 33 |
|
|
2021
Q1 | $2.53M | Sell |
5,174
-80
| -2% | -$40.1K | 0.58% | 42 |
|
|
2020
Q4 | $2.78M | Sell |
5,254
-247
| -4% | -$111K | 0.63% | 32 |
|
|
2020
Q3 | $2.63M | Sell |
5,501
-25
| -0.5% | -$9.24K | 0.72% | 34 |
|
|
2020
Q2 | $2.07M | Sell |
5,526
-177
| -3% | -$51.2K | 0.65% | 38 |
|
|
2020
Q1 | $1.53M | Sell |
5,703
-253
| -4% | -$66K | 0.59% | 44 |
|
|
2019
Q4 | $1.7M | Sell |
5,956
-70
| -1% | -$18.4K | 0.57% | 50 |
|
|
2019
Q3 | $1.68M | Sell |
6,026
-209
| -3% | -$58.2K | 0.63% | 48 |
|
|
2019
Q2 | $1.74M | Buy |
6,235
+7
| +0.1% | +$1.73K | 0.71% | 47 |
|
|
2019
Q1 | $1.39M | Hold |
6,228
| – | – | 0.61% | 50 |
|
|
2018
Q4 | $1.16M | Buy |
+6,228
| New | +$1.28M | 0.64% | 47 |
|
Other funds holding IDXX
Means Investment Company's IDXX Position: Q2 2026 in Review
Means Investment Company reduced its Idexx Laboratories (IDXX) stake by 0.17% in Q2 2026, selling an estimated $1.68K and leaving 1,813 shares worth $955K. The position accounts for 0.07% of the portfolio, ranked #91.
Means Investment Company first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.19M in Q4 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Means Investment Company held 1,813 shares of Idexx Laboratories worth $955K as of Q2 2026.
- Means Investment Company sold 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
- Idexx Laboratories made up 0.07% of Means Investment Company's portfolio in Q2 2026, its #91 holding.
- Means Investment Company first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
- Means Investment Company's Idexx Laboratories position peaked at $3.19M in Q4 2021.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.